Get the Stockscreener App
3.42
0.00%
+0.00
After Hours:
3.51
0.09
+2.63%
Sutro Biopharma Inc Stock (STRO) Forecast
The Sutro Biopharma Inc (STRO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.3672, representing a +86.18% increase from the current price of $3.42. The highest analyst price target is $7.7408, and the lowest is $4.9937.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month STRO Price Target
Average 6.1107
(+78.67% Upside)
Is Sutro Biopharma Inc (STRO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.64 | Neutral |
| STOCH(9,6) | 12.38 | Buy |
| STOCHRSI(14) | 12.84 | Buy |
| MACD(12,26) | -0.2654 | Sell |
| ADX(14) | 15.66 | Neutral |
| William %R | -91.72 | Buy |
| CCI(14) | -104.53 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.708
Sell
|
3.7212
Sell
|
| MA20 |
4.2193
Sell
|
3.9655
Sell
|
| MA50 |
4.3492
Sell
|
4.1852
Sell
|
| MA100 |
4.2603
Sell
|
4.1742
Sell
|
| MA200 |
3.9766
Sell
|
4.3459
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, STRO could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on STRO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.64 indicates that STRO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.38 indicates that STRO is oversold. This indicates that STRO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.84 indicates that STRO is oversold. This suggests that STRO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.66 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -104.53 indicates that STRO is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term STRO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sutro Biopharma Inc financial reports and earnings history, Sutro Biopharma Inc (STRO) stock could reach $2.795 by 2030, $2.3692 by 2040 and $4.7288 by 2050. See the projected annual prices until 2050 of the Sutro Biopharma Inc stock below:
- Sutro Biopharma Inc (STRO) is expected to reach an average price of $1.9533 in 2035, with a high prediction of $1.2483 and a low estimate of $0.985. This indicates an $-42.89% rise from the last recorded price of $3.42.
- Sutro Biopharma Inc (STRO) stock is projected to chart a bullish course in 2040, with an average price target of $2.8392, representing an $-16.98% surge from its current level. The forecast ranges from a conservative $2.0206 to a sky-high $2.3692.
- Our analysts predict Sutro Biopharma Inc (STRO) to jump 61.54% by 2045, soaring from $4.7981 to an average price of $5.5247, potentially reaching $5.3167. While $4.7981 is the low estimate, the potential upside is significant.
- Sutro Biopharma Inc (STRO) stock is expected to climb by 2050, reaching an average of $5.5797, a $63.15% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.7288 and $5.4794, respectively, highlighting the market's uncertainty.
Sutro Biopharma Inc Stock (STRO) Year by Year Forecast
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2024
Our forecast for STRO stock price in 2024 now indicates an average price target of $5.8498 with a high forecast of $8.2101 and a low forecast of $3.4894. The average prediction reflects an increase of +71.05% from the last recorded price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $5.8646 | $4.9937 | $7.7408 | +71.48% |
| June, 2024 | $7.0663 | $5.3014 | $7.5163 | +106.62% |
| July, 2024 | $7.496 | $6.4542 | $8.2101 | +119.18% |
| August, 2024 | $7.3027 | $6.5598 | $7.7039 | +113.53% |
| September, 2024 | $3.8074 | $3.4894 | $7.4456 | +11.33% |
| October, 2024 | $5.2697 | $3.5253 | $7.3332 | +54.09% |
| November, 2024 | $5.8008 | $3.855 | $6.4302 | +69.62% |
| December, 2024 | $6.8105 | $5.4767 | $7.5025 | +99.14% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2025
Sutro Biopharma Inc Stock (STRO) is expected to reach an average price of $6.1324 in 2025, with a high prediction of $10.19 and a low estimate of $2.0713. This indicates an +79.31% rise from the last recorded price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.0923 | $5.7643 | $7.4343 | +107.38% |
| February, 2025 | $7.649 | $6.2002 | $8.114 | +123.65% |
| March, 2025 | $8.1737 | $5.6457 | $8.7319 | +139.00% |
| April, 2025 | $5.6354 | $4.7275 | $8.1816 | +64.78% |
| May, 2025 | $6.0671 | $2.0713 | $7.0206 | +77.40% |
| June, 2025 | $5.9268 | $4.9234 | $7.3068 | +73.30% |
| July, 2025 | $5.9486 | $3.9506 | $6.6306 | +73.93% |
| August, 2025 | $5.4803 | $4.6624 | $6.5494 | +60.24% |
| September, 2025 | $5.31 | $3.2482 | $6.09 | +55.26% |
| October, 2025 | $4.7317 | $3.5258 | $5.8817 | +38.35% |
| November, 2025 | $8.8234 | $4.7096 | $10.19 | +158.00% |
| December, 2025 | $6.4831 | $6.0567 | $9.6114 | +89.56% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2026
The predicted value for Sutro Biopharma Inc (STRO) in 2026 is set at an average of $15.70. Estimates vary from a peak of $24.78 to a trough of $6.616, indicating an +359.03% surge from the present price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.2148 | $6.616 | $9.7947 | +169.44% |
| February, 2026 | $13.49 | $8.9728 | $15.56 | +294.34% |
| March, 2026 | $18.51 | $12.55 | $21.89 | +441.12% |
| April, 2026 | $24.00 | $16.94 | $24.55 | +601.70% |
| May, 2026 | $20.93 | $17.68 | $24.78 | +511.98% |
| June, 2026 | $19.27 | $15.55 | $22.41 | +463.43% |
| July, 2026 | $16.57 | $14.77 | $20.72 | +384.54% |
| August, 2026 | $14.87 | $14.24 | $17.98 | +334.82% |
| September, 2026 | $16.55 | $14.14 | $16.95 | +383.99% |
| October, 2026 | $14.92 | $14.40 | $16.83 | +336.38% |
| November, 2026 | $15.59 | $13.13 | $15.70 | +355.96% |
| December, 2026 | $18.47 | $14.55 | $19.29 | +439.93% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sutro Biopharma Inc (STRO) is $10.48, with a high forecast of $20.52 and a low forecast of $0.4386. This indicates an +206.34% increase from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $15.67 | $15.03 | $18.69 | +358.11% |
| February, 2027 | $15.85 | $14.91 | $16.61 | +363.43% |
| March, 2027 | $13.02 | $12.64 | $20.52 | +280.67% |
| April, 2027 | $12.68 | $11.13 | $14.55 | +270.78% |
| May, 2027 | $6.9802 | $6.5223 | $13.00 | +104.10% |
| June, 2027 | $5.782 | $5.662 | $7.8982 | +69.06% |
| July, 2027 | $5.1437 | $4.9679 | $6.2099 | +50.40% |
| August, 2027 | $5.5734 | $4.6296 | $6.7396 | +62.96% |
| September, 2027 | $3.0551 | $2.9851 | $6.1813 | -10.67% |
| October, 2027 | $1.5169 | $1.2469 | $3.8131 | -55.65% |
| November, 2027 | $1.4365 | $0.4386 | $1.9407 | -58.00% |
| December, 2027 | $2.9983 | $1.1345 | $3.6083 | -12.33% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2028
In 2028, Sutro Biopharma Inc (STRO) is projected to reach an average price of $3.8468, with a high projection of $6.0904 and a low estimate of $1.6033. This indicates an +12.48% rise from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.788 | $2.4021 | $4.36 | +10.76% |
| February, 2028 | $3.0397 | $2.6938 | $3.9559 | -11.12% |
| March, 2028 | $2.7514 | $2.2806 | $3.2414 | -19.55% |
| April, 2028 | $4.6132 | $2.4494 | $4.7032 | +34.89% |
| May, 2028 | $4.8128 | $4.2328 | $5.6837 | +40.73% |
| June, 2028 | $4.2246 | $3.8246 | $5.5387 | +23.53% |
| July, 2028 | $4.8942 | $3.8525 | $6.0904 | +43.11% |
| August, 2028 | $3.646 | $3.326 | $4.8822 | +6.61% |
| September, 2028 | $2.5877 | $2.4677 | $3.9139 | -24.34% |
| October, 2028 | $1.8974 | $1.6245 | $3.3957 | -44.52% |
| November, 2028 | $3.1691 | $1.6033 | $3.2712 | -7.34% |
| December, 2028 | $2.2809 | $1.9009 | $3.6421 | -33.31% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2029
The 2029 price forecast for Sutro Biopharma Inc Stock (STRO) is $1.8826 on average, with a high prediction of $3.7198 and a low estimate of $0.0454. This represents an -44.95% decrease from the previous price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.2605 | $2.1326 | $3.2067 | -33.90% |
| February, 2029 | $2.1023 | $1.9293 | $2.7414 | -38.53% |
| March, 2029 | $2.264 | $1.6461 | $2.404 | -33.80% |
| April, 2029 | $1.0037 | $0.9437 | $2.6319 | -70.65% |
| May, 2029 | $0.9254 | $0.7496 | $1.8475 | -72.94% |
| June, 2029 | $0.1528 | $0.2028 | $1.0084 | -95.53% |
| July, 2029 | $1.3768 | $0.079 | $1.4718 | -59.74% |
| August, 2029 | $0.0159 | $0.4241 | $2.1577 | -99.54% |
| September, 2029 | $1.6093 | $0.1283 | $3.0776 | -52.94% |
| October, 2029 | $1.7787 | $0.8128 | $3.0728 | -47.99% |
| November, 2029 | $2.6522 | $0.0454 | $2.6822 | -22.45% |
| December, 2029 | $1.4515 | $1.3815 | $3.7198 | -57.56% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2030
Sutro Biopharma Inc Stock (STRO) is expected to reach an average price of $2.3954 in 2030, with a high forecast of $4.7139 and a low forecast of $0.077. This signifies an -29.96% decrease from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.435 | $0.6424 | $2.795 | -28.80% |
| February, 2030 | $3.2585 | $0.9818 | $3.6685 | -4.72% |
| March, 2030 | $3.2319 | $2.4512 | $3.9302 | -5.50% |
| April, 2030 | $2.5563 | $2.3195 | $3.4478 | -25.26% |
| May, 2030 | $0.3853 | $0.077 | $2.4271 | -88.74% |
| June, 2030 | $1.1088 | $0.2365 | $3.1565 | -67.58% |
| July, 2030 | $1.4276 | $0.29 | $2.7376 | -58.26% |
| August, 2030 | $2.721 | $1.3634 | $3.4051 | -20.44% |
| September, 2030 | $2.5304 | $1.6986 | $3.3904 | -26.01% |
| October, 2030 | $3.9539 | $2.4963 | $4.7139 | +15.61% |
| November, 2030 | $4.1873 | $1.6515 | $4.5073 | +22.44% |
| December, 2030 | $0.3717 | $0.4183 | $4.2032 | -89.13% |
1.53%
3.38%
Cap:
|
Volume (24h):